Wednesday, 16 August 2017

Japan News

  • MIT, Kyoto researchers invent RNA-based gene circuits

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 04 Aug, 2015

    Tokyo: A joint collaboration between the researchers at Massachusetts Institute of Technology (MIT) and the Center for iPS Cell Research and Application (CiRA), Kyoto University, has led t...Read more

  • Japan creates sperm bank for endangered species

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013

    Singapore: Researchers at the Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Japan, have preserved sperm taken from two endangered primates and a type of gi...Read more

  • Takeda close to releasing Norovirus vaccine

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013

    Singapore: Japan's drug major Takeda Pharmaceutical has said that they are set to finish the early stage human studies on a vaccine against norovirus, by the end of this year. Takeda's vacc...Read more

  • Challenges in mHealth integration'

    Japan |  Opinion | By Amrita Tejasvi | 0 Comment | 19 Jan, 2016

    Singapore: Medidata Solutions is a provider of cloud computing-based solutions for clinical development process to improve study design, protocol development, trial planning and management,...Read more

  • TriReme catheter gets approval in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 21 Nov, 2013

    Singapore: TriReme Medical's Japanese partner Century Medical has received Shonin approval, the approval to market in Japan, for the GliderXtreme PTA catheter for the treatment of periphera...Read more

  • Medtronic's CoreValve system approved in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 01 Apr, 2015

    Medical device manufacturer Medtronic has announced Japanese regulatory approval for the self-expanding transcatheter CoreValve System for patients with severe aortic stenosis (AS) unable t...Read more

  • Takeda, DND to accelerate drug discovery for parasite infection

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 29 Jul, 2015

    Singapore: Geneva based Drugs for Neglected Diseases and Japan's Takeda have collaborated for a Lead Optimization Program aimed at identifying the best compound among aminopyrazole series f...Read more

  • ReproCELL to launch human iPS-derived neurons

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 08 Jun, 2012

    Singapore: ReproCELL, which commercializes human pluripotent stem cells as an effective tool for drug discovery and development, will start commercializing its human iPS-derived neurons in ...Read more

  • Abbott marks success with naturally dissolving stent in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2015

    Global life sciences company Abbott has announced that the company has observed positive clinical results from ABSORB Japan, a multi-center, one-year randomized trial comparing the safety a...Read more

  • Takeda selected for Dow Jones social responsibility index

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 27 Sep, 2012

    Singapore: Takeda Pharmaceutical has been selected for the third consecutive year for the Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pacific), the Asia Pacific version of the D...Read more

  • ICON appoints APAC and Japan VPs

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 03 Nov, 2015

    Singapore: ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has appointed Ms Mary Pan as vice president...Read more

  • Daiichi Sankyo launches LIXIANA sales alliance in Europe

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 Feb, 2016

    Singapore: Daiichi Sankyo announced that its European subsidiary, Daiichi Sankyo Europe (DSE) GmbH Group has granted exclusive rights to Merck & Co, known as MSD outside the US and Cana...Read more

  • Eisai subsidiary announces cancer trial results

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 15 Jan, 2013

    Singapore: Eisai announced the preliminary results of its global phase III study (Study FAR 131, MORAb-003-004) of farletuzumab (MORAb-003), an investigational compound under development a...Read more

  • Positive results for Otsuka's MDR-TB treatment

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2012

    Singapore: Clinical trial results on the safety and efficacy of delamanid, Otsuka Pharmaceutical's investigational compound for the treatment of multidrug-resistant tuberculosis (MDR-TB), s...Read more

  • Naveed Shams is CEO of Santen US subsidiary

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 13 Mar, 2013

    Singapore: Japan-based Santen Pharmaceutical appointed Dr Naveed Shams as president, CEO and chief scientific officer of Santen. Prior to this new appointment, Dr Shams was VP and head of G...Read more

  • “We think India is a worthy country to expand our business”

    Japan |  Opinion | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2015

    Could you briefly outline CMIC's profile and its presence in Japan? I can proudly admit that CMIC is the first Contract Research Organization in Japan. In 1992, CMIC Group pioneered the CR...Read more

  • Astellas, FHU study finds neurogenesis deficits in schizophrenics

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 26 Jul, 2012

    Singapore: A new research study has found deficits in the maturation steps of neurogenesis within the hippocampus of patients with schizophrenia or bipolar disorder. The research was conduc...Read more

  • Academia, industry team up for Japan's genomic research project

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 31 Aug, 2015

    Singapore: Led by the National Cancer Center of Japan, a joint research pact has been inked by many private companies and academic institutions to discover new drugs based on human genetic ...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls